Zifi-O Tablet is a combination antibiotic formulation containing Cefixime 200mg and Ofloxacin 200mg, designed for the effective treatment of a broad spectrum of bacterial infections. Cefixime, a third-generation cephalosporin, acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, while Ofloxacin, a fluoroquinolone, interferes with bacterial DNA gyrase and topoisomerase IV, thereby preventing DNA replication and transcription. This synergistic combination enhances antibacterial efficacy against both Gram-positive and Gram-negative pathogens, making Zifi-O suitable for infections such as urinary tract infections, respiratory tract infections, gastrointestinal infections, and certain sexually transmitted infections. It is indicated in cases where monotherapy may be insufficient or resistance patterns necessitate combination therapy. Zifi-O should be administered as prescribed by a healthcare professional, with dosage adjustments based on the severity of infection, renal function, and patient-specific factors. Common side effects may include gastrointestinal disturbances, headache, dizziness, and hypersensitivity reactions. Caution is advised in patients with a history of hypersensitivity to cephalosporins or fluoroquinolones, and it is contraindicated in individuals with known tendon disorders related to fluoroquinolone use. Proper adherence to the prescribed course is essential to prevent the development of antibiotic resistance.